Medico-legal perspectives on sudden cardiac death in young athletes

[1]  B. Maron,et al.  Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry. , 2016, The American journal of medicine.

[2]  B. Maron,et al.  Comparison of the Frequency of Sudden Cardiovascular Deaths in Young Competitive Athletes Versus Nonathletes: Should We Really Screen Only Athletes? , 2016, The American journal of cardiology.

[3]  P. Noseworthy,et al.  Bileaflet Mitral Valve Prolapse and Risk of Ventricular Dysrhythmias and Death , 2016, Journal of cardiovascular electrophysiology.

[4]  R. Page,et al.  Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force , 2016, Journal of the American College of Cardiology.

[5]  J. Prutkin,et al.  Response to Letter Regarding Article, "Incidence, Cause, and Comparative Frequency of Sudden Cardiac Death in National Collegiate Athletic Association Athletes: A Decade in Review". , 2016, Circulation.

[6]  C. Schmied,et al.  Sports-related sudden cardiac death in Switzerland classified by static and dynamic components of exercise , 2016, European journal of preventive cardiology.

[7]  K. Maemura,et al.  Relationships Between Clinical Characteristics and Decreased Plakoglobin and Connexin 43 Expressions in Myocardial Biopsies From Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. , 2015, International heart journal.

[8]  William J. Bryant,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology. , 2015, Circulation.

[9]  B. Levine,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology. , 2015, Circulation.

[10]  M. Link,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Associat , 2015, Circulation.

[11]  R. Myerburg,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology. , 2015, Journal of the American College of Cardiology.

[12]  B. Maron,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology. , 2015, Circulation.

[13]  G. Gerosa,et al.  TGF-beta1 pathway activation and adherens junction molecular pattern in nonsyndromic mitral valve prolapse. , 2015, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[14]  M. Wilhelm,et al.  Sudden cardiac death among general population and sport related population in forensic experience. , 2015, Journal of forensic and legal medicine.

[15]  H. Bundgaard,et al.  Next-generation sequencing of 100 candidate genes in young victims of suspected sudden cardiac death with structural abnormalities of the heart , 2015, International Journal of Legal Medicine.

[16]  D. Corrado,et al.  Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death , 2015, Circulation.

[17]  M. Link,et al.  Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2015, Circulation.

[18]  S. Mörner,et al.  Genetic screening in sudden cardiac death in the young can save future lives , 2015, International Journal of Legal Medicine.

[19]  M. Link,et al.  Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. , 2015, European heart journal.

[20]  M. Emery,et al.  Legal and Ethical Issues in the Cardiovascular Care of Elite Athletes. , 2015, Clinics in sports medicine.

[21]  R. Battle,et al.  Something Old, Something New: Using Family History and Genetic Testing to Diagnose and Manage Athletes with Inherited Cardiovascular Disease. , 2015, Clinics in sports medicine.

[22]  H. Bundgaard,et al.  Next-generation sequencing of 34 genes in sudden unexplained death victims in forensics and in patients with channelopathic cardiac diseases , 2015, International Journal of Legal Medicine.

[23]  M. Wilhelm,et al.  Sudden cardiac death in forensic medicine – Swiss recommendations for a multidisciplinary approach. , 2015, Swiss medical weekly.

[24]  N. Garritano,et al.  Student athletes, sudden cardiac death, and lifesaving legislation: a review of the literature. , 2015, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.

[25]  A. Baggish.  A decade of athlete ECG criteria: where we've come and where we're going. , 2015, Journal of electrocardiology.

[26]  J. Sweeting,et al.  Sudden cardiac death in athletes , 2015, BMJ : British Medical Journal.

[27]  E. Arbustini,et al.  Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases? , 2014, Journal of the American College of Cardiology.

[28]  C. Ackerley,et al.  TMEM43 Mutation p.S358L Alters Intercalated Disc Protein Expression and Reduces Conduction Velocity in Arrhythmogenic Right Ventricular Cardiomyopathy , 2014, PloS one.

[29]  J. Schläpfer,et al.  Sudden cardiac death in the young (5-39 years) in the canton of Vaud, Switzerland , 2014, BMC Cardiovascular Disorders.

[30]  A. Holst,et al.  Sports-related sudden cardiac death in a competitive and a noncompetitive athlete population aged 12 to 49 years: data from an unselected nationwide study in Denmark. , 2014, Heart rhythm.

[31]  J. Saul,et al.  Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 Years of Age): a scientific statement from the American Heart Association and the American College of Cardiology. , 2014, Circulation.

[32]  J. Brugada,et al.  Usefulness of echocardiography in preparticipation screening of competitive athletes. , 2014, Revista espanola de cardiologia.

[33]  J. Brugada,et al.  Utilidad del ecocardiograma en la revisión preparticipativa de deportistas de competición , 2014 .

[34]  K. Harmon,et al.  Incidence of sudden cardiac arrest in high school student athletes on school campus. , 2014, Heart rhythm.

[35]  B. Maron,et al.  Strategies for assessing the prevalence of cardiovascular sudden deaths in young competitive athletes. , 2014, International journal of cardiology.

[36]  B. Maron,et al.  Incidence and causes of sudden death in U.S. college athletes. , 2014, Journal of the American College of Cardiology.

[37]  A. Wilde,et al.  T-Cell–Mediated Inflammatory Activity in the Stellate Ganglia of Patients With Ion-Channel Disease and Severe Ventricular Arrhythmias , 2014, Circulation. Arrhythmia and electrophysiology.

[38]  J. Smeets,et al.  Legal responsibilities of physicians when making participation decisions in athletes with cardiac disorders: Do guidelines provide a solid legal footing? , 2014, British Journal of Sports Medicine.

[39]  Mathew G. Wilson,et al.  Comparison of Electrocardiographic Criteria for the Detection of Cardiac Abnormalities in Elite Black and White Athletes , 2014, Circulation.

[40]  R. Brugada,et al.  Negative autopsy and sudden cardiac death , 2014, International Journal of Legal Medicine.

[41]  C. Tracy,et al.  HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. , 2013, Heart rhythm.

[42]  Yongkeun Cho,et al.  Clinical usefulness of immunohistochemistry for plakoglobin, N-cadherin, and connexin-43 in the diagnosis of arrhythmogenic right ventricular cardiomyopathy. , 2013, International journal of clinical and experimental pathology.

[43]  Michael J Ackerman,et al.  The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy. , 2013, European heart journal.

[44]  S. Russell,et al.  Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.

[45]  G. Thiene,et al.  Is it time for plakoglobin immune-histochemical diagnostic test for arrhythmogenic cardiomyopathy in the routine pathology practice? , 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[46]  J. Bytomski,et al.  Medicolegal aspects of sports medicine. , 2013, Primary care.

[47]  E. Behr,et al.  Sudden Cardiac Death With Autopsy Findings of Uncertain Significance: Potential for Erroneous Interpretation , 2013, Circulation. Arrhythmia and electrophysiology.

[48]  Catherine R. Rahilly-Tierney,et al.  Regular Physical Activity and Risk of Atrial Fibrillation: A Systematic Review and Meta-analysis , 2013, Circulation. Arrhythmia and electrophysiology.

[49]  M. Papadakis,et al.  Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. , 2013, Journal of the American College of Cardiology.

[50]  V. Pascali,et al.  Genetics of arrhythmogenic right ventricular cardiomyopathy , 2013, Journal of Medical Genetics.

[51]  B. Maron,et al.  Incidence of cardiovascular sudden deaths in Minnesota high school athletes. , 2013, Heart rhythm.

[52]  D. Corrado,et al.  Screening of competitive athletes to prevent sudden death , 2013, Heart.

[53]  Matt Reed,et al.  Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? , 2013, Heart.

[54]  Christopher L Higgins,et al.  Sudden Cardiac Death in Young Athletes: Preparticipation Screening for Underlying Cardiovascular Abnormalities and Approaches to Prevention , 2013, The Physician and sportsmedicine.

[55]  Neil M. Johannsen,et al.  Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[56]  J. Drezner.  Detect, manage, inform: a paradigm shift in the care of athletes with cardiac disorders? , 2012, British Journal of Sports Medicine.

[57]  R. Elosúa,et al.  Sudden death. , 2012, Revista espanola de cardiologia.

[58]  M. Link,et al.  Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. , 2012, The American journal of cardiology.

[59]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.

[60]  M. Ackerman,et al.  Competitive sports participation in athletes with congenital long QT syndrome. , 2012, JAMA.

[61]  Mathew G. Wilson,et al.  Advising a cardiac disease gene positive yet phenotype negative or borderline abnormal athlete: Is sporting disqualification really necessary? , 2012, British Journal of Sports Medicine.

[62]  Bengt Johansson,et al.  Hyaluronan and Collagen in Human Hypertrophic Cardiomyopathy: A Morphological Analysis , 2012, Cardiology research and practice.

[63]  J. Brugada,et al.  Genetics of sudden cardiac death in children and young athletes , 2012, Cardiology in the Young.

[64]  P. Schwartz,et al.  Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant. , 2012, Heart rhythm.

[65]  P. Berne,et al.  Brugada syndrome 2012. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[66]  M. Sheppard.  Aetiology of sudden cardiac death in sport: a histopathologist's perspective , 2012, British Journal of Sports Medicine.

[67]  J. Triedman,et al.  PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm So , 2012, Heart rhythm.

[68]  M. Link,et al.  Sudden cardiac death in the athlete: bridging the gaps between evidence, policy, and practice. , 2012, Circulation.

[69]  D. Corrado,et al.  Pathophysiology of arrhythmogenic cardiomyopathy , 2012, Nature Reviews Cardiology.

[70]  M. Laakso,et al.  Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy , 2012, Heart.

[71]  D. Corrado,et al.  Prevalence of Cardiomyopathy in Italian Asymptomatic Children With Electrocardiographic T-Wave Inversion at Preparticipation Screening , 2012, Circulation.

[72]  P. Thompson,et al.  Acute coronary thrombosis in Boston marathon runners. , 2012, The New England journal of medicine.

[73]  J. Drezner.  ECG screening in athletes: time to develop infrastructure. , 2011, Heart rhythm.

[74]  E. Ashley,et al.  Interpretation of the Electrocardiogram of Young Athletes , 2011, Circulation.

[75]  J. Le Heuzey,et al.  Sports-Related Sudden Death in the General Population , 2011, Circulation.

[76]  Yan Chaowu,et al.  Histopathological features of delayed enhancement cardiovascular magnetic resonance in isolated left ventricular noncompaction. , 2011, Journal of the American College of Cardiology.

[77]  Joshua T. Cohen,et al.  Screening for Sudden Cardiac Death in the Young: Report From a National Heart, Lung, and Blood Institute Working Group , 2011, Circulation.

[78]  P. Mangin,et al.  Genetic analysis of sudden cardiac death victims: a survey of current forensic autopsy practices , 2011, International Journal of Legal Medicine.

[79]  Jonathan A Drezner,et al.  Incidence of Sudden Cardiac Death in National Collegiate Athletic Association Athletes , 2011, Circulation.

[80]  S. Viskin,et al.  Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? , 2011, Journal of the American College of Cardiology.

[81]  J. Svendsen,et al.  Incidence and etiology of sports-related sudden cardiac death in Denmark--implications for preparticipation screening. , 2010, Heart rhythm.

[82]  H. Heidbuchel,et al.  Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin , 2010, Heart.

[83]  P. Mangin,et al.  When Information Can Save Lives: The Duty to Warn Relatives about Sudden Cardiac Death and Environmental Risks , 2010, The Hastings Center report.

[84]  R. Brugada,et al.  Genetics of Brugada syndrome , 2010, Current opinion in cardiology.

[85]  B. Maron.  National Electrocardiography Screening for Competitive Athletes: Feasible in the United States? , 2010, Annals of Internal Medicine.

[86]  E. Ashley,et al.  Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young Athletes , 2010, Annals of Internal Medicine.

[87]  M. Picard,et al.  Cardiovascular Screening in College Athletes With and Without Electrocardiography , 2010, Annals of Internal Medicine.

[88]  Barry J Maron,et al.  Recommendations for interpretation of 12-lead electrocardiogram in the athlete. , 2009, European heart journal.

[89]  Fabio Mosca,et al.  Prevalence of the Congenital Long-QT Syndrome , 2009, Circulation.

[90]  J. Nielsen,et al.  Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[91]  J. Hodges,et al.  Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. , 2009, The American journal of cardiology.

[92]  J. Manson,et al.  Relation of vigorous exercise to risk of atrial fibrillation. , 2009, The American journal of cardiology.

[93]  K. Swedberg,et al.  Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. , 2009, European heart journal.

[94]  D. Corrado,et al.  Arrhythmogenic right ventricular cardiomyopathy , 2009, The Lancet.

[95]  K. Jöckel,et al.  Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. , 2009, Radiology.

[96]  B. Maron,et al.  Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006 , 2009, Circulation.

[97]  B. Maron,et al.  Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. , 2008, Journal of the American College of Cardiology.

[98]  Hugh Calkins,et al.  A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. , 2008, The New England journal of medicine.

[99]  D. Siscovick,et al.  American Heart Association/american College of Cardiology Foundation/heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardi , 2008, Heart rhythm.

[100]  Curt D. Furberg,et al.  Physical Activity and Incidence of Atrial Fibrillation in Older Adults: The Cardiovascular Health Study , 2008, Circulation.

[101]  R. Myerburg,et al.  Electrocardiograms Should Be Included in Preparticipation Screening of Athletes , 2007, Circulation.

[102]  B. Chaitman.  An Electrocardiogram Should Not Be Included in Routine Preparticipation Screening of Young Athletes , 2007, Circulation.

[103]  W. Roberts,et al.  The editor's roundtable: sudden cardiac death in athletes. , 2007, The American journal of cardiology.

[104]  A. Pelliccia,et al.  Prevalence of abnormal electrocardiograms in a large, unselected population undergoing pre-participation cardiovascular screening. , 2007, European heart journal.

[105]  Fernando Costa,et al.  Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. , 2007, Circulation.

[106]  S. Viskin.  Antagonist: routine screening of all athletes prior to participation in competitive sports should be mandatory to prevent sudden cardiac death. , 2007, Heart rhythm.

[107]  D. Corrado,et al.  Protagonist: routine screening of all athletes prior to participation in competitive sports should be mandatory to prevent sudden cardiac death. , 2007, Heart rhythm.

[108]  B. Maron,et al.  Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update: A Scientific Statement From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism Endorsed by the American College of Cardi , 2007, Circulation.

[109]  P. Angelini.  Coronary Artery Anomalies: An Entity in Search of an Identity , 2007, Circulation.

[110]  I. Riezzo,et al.  Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders , 2006, International Journal of Legal Medicine.

[111]  B. Maron,et al.  Abstract 3872: Profile and Frequency of Sudden Deaths in 1,463 Young Competitive Athletes: From a 25-year U.S. National Registry, 1980 2005 , 2006 .

[112]  Barry J Maron,et al.  The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. , 2006, Circulation.

[113]  Maurizio Schiavon,et al.  Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. , 2006, JAMA.

[114]  D. Corrado,et al.  Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers , 2006, European Journal of Cardiovascular Prevention & Rehabilitation.

[115]  J. Elefteriades,et al.  Weight Lifting and Aortic Dissection: More Evidence for a Connection , 2006, Cardiology.

[116]  B. Maron,et al.  Medical and legal issues in the cardiovascular evaluation of competitive athletes. , 2005, JAMA.

[117]  C. Chow,et al.  Sudden death in the young. , 2005, Heart rhythm.

[118]  M. Link,et al.  Cardiovascular toxicities of performance-enhancing substances in sports. , 2005, Mayo Clinic proceedings.

[119]  A. Wilde,et al.  Sudden Unexplained Death: Heritability and Diagnostic Yield of Cardiological and Genetic Examination in Surviving Relatives , 2005, Circulation.

[120]  B. Maron,et al.  Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. , 2005, Journal of the American College of Cardiology.

[121]  J. Towbin,et al.  Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. , 2005, Journal of the American College of Cardiology.

[122]  G. V. Van Hare,et al.  Task Force 7: arrhythmias. , 2005, Journal of the American College of Cardiology.

[123]  V. Kosma,et al.  Atherosclerosis-like lesions of the aortic valve are common in adults of all ages: a necropsy study , 2005, Heart.

[124]  R. Virmani,et al.  Left ventricular noncompaction: a pathological study of 14 cases. , 2005, Human pathology.

[125]  Lisa Pearse,et al.  Sudden Death in Young Adults: A 25-Year Review of Autopsies in Military Recruits , 2004, Annals of Internal Medicine.

[126]  D. Tester,et al.  Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases. , 2004, Mayo Clinic proceedings.

[127]  J. Ménard,et al.  Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up. , 2004, Journal of the American College of Cardiology.

[128]  A. Jahangir,et al.  Dysrhythmias and the athlete. , 2004, AACN clinical issues.

[129]  J. Gorman,et al.  Fibrillin and other matrix proteins in mitral valve prolapse syndrome. , 2004, The Annals of thoracic surgery.

[130]  J. Juang,et al.  Brugada Syndrome – An Under-Recognized Electrical Disease in Patients with Sudden Cardiac Death , 2004, Cardiology.

[131]  J. Elefteriades,et al.  Weight lifting and rupture of silent aortic aneurysms. , 2003, JAMA.

[132]  Maurizio Schiavon,et al.  Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.

[133]  B. Maron.  Sudden death in young athletes. , 2003, New England Journal of Medicine.

[134]  Sanjay Sharma.  Physiological Society Symposium – the Athlete's Heart , 2003 .

[135]  A. Arauz,et al.  Stroke Associated With Sympathomimetics Contained in Over-the-Counter Cough and Cold Drugs , 2003, Stroke.

[136]  Paul G Shekelle,et al.  Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. , 2003, JAMA.

[137]  O. Alfieri,et al.  Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. , 2003, Journal of the American College of Cardiology.

[138]  B. McCrindle,et al.  Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? , 2003, Journal of the American College of Cardiology.

[139]  B. Maron,et al.  Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. , 2002, Journal of the American College of Cardiology.

[140]  Carlo Napolitano,et al.  Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia , 2002, Circulation.

[141]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[142]  G. Thiene,et al.  Active versus borderline myocarditis: clinicopathological correlates and prognostic implications , 2002, Heart.

[143]  B. Maron,et al.  Remodeling of Left Ventricular Hypertrophy in Elite Athletes After Long-Term Deconditioning , 2002, Circulation.

[144]  M. Davies,et al.  Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[145]  M. Koester.  A Review of Sudden Cardiac Death in Young Athletes and Strategies for Preparticipation Cardiovascular Screening. , 2001, Journal of athletic training.

[146]  D. Corrado,et al.  Sudden cardiac death in young people with apparently normal heart. , 2001, Cardiovascular research.

[147]  Fineschi,et al.  Anabolic steroid abuse and cardiac sudden death: a pathologic study. , 2001, Archives of pathology & laboratory medicine.

[148]  S. Priori,et al.  Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia , 2001, Circulation.

[149]  N. Benowitz,et al.  Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids , 2000 .

[150]  A. Angelini,et al.  Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis , 2000, Heart.

[151]  B. Maron,et al.  Clinical significance of abnormal electrocardiographic patterns in trained athletes. , 2000, Circulation.

[152]  D. Corrado,et al.  Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. , 2000, Journal of the American College of Cardiology.

[153]  J. Karjalainen,et al.  Incidence of three presentations of acute myocarditis in young men in military service. A 20-year experience. , 1999, European heart journal.

[154]  A. Pelliccia,et al.  Physiologic Left Ventricular Cavity Dilatation in Elite Athletes , 1999, Annals of Internal Medicine.

[155]  Barry I. Maron.  Cardiovascular Risks to Young Persons on the Athletic Field , 1998, Annals of Internal Medicine.

[156]  M. Davies,et al.  Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. , 1997, Journal of the American College of Cardiology.

[157]  F O Mueller,et al.  Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.

[158]  D. Corrado,et al.  Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. , 1996, Journal of the American College of Cardiology.

[159]  H. Wellens,et al.  Aborted sudden death in the Wolff-Parkinson-White syndrome. , 1995, The American journal of cardiology.

[160]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[161]  R. Cantu,et al.  Nontraumatic sports death in high school and college athletes. , 1995, Medicine and science in sports and exercise.

[162]  B. Maron,et al.  Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. , 1995, The American journal of cardiology.

[163]  B. Maron,et al.  Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. , 1995, Circulation.

[164]  K. Nolte,et al.  Stroke associated with ephedrine use , 1993, Neurology.

[165]  J. Brugada,et al.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.

[166]  I. Piña,et al.  Statement on exercise. Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart association. , 1992, Circulation.

[167]  B. Fernhall,et al.  The blood pressure response to exercise in anabolic steroid users. , 1992, Medicine and science in sports and exercise.

[168]  M. Proschan,et al.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. , 1991, The New England journal of medicine.

[169]  A. Tilkian,et al.  Coronary artery spasm and myocardial infarction in a patient with normal coronary arteries: temporal relationship to pseudoephedrine ingestion. , 1990, Catheterization and cardiovascular diagnosis.

[170]  H. Kulbertus.  Ventricular arrhythmias, syncope and sudden death in aortic stenosis. , 1988, European heart journal.

[171]  P. Kligfield,et al.  Arrhythmias and sudden death in mitral valve prolapse. , 1987, American heart journal.

[172]  L. Kuller,et al.  Sudden and unexpected natural death in childhood and adolescence. , 1985, JAMA.

[173]  W Q Sturner,et al.  Incidence of death during jogging in Rhode Island from 1975 through 1980. , 1982, JAMA.

[174]  W. Roberts,et al.  Sudden Death in Young Athletes , 1980, Circulation.

[175]  L. To,et al.  EPHEDRINE‐INDUCED CARDIOMYOPATHY , 1980, The Medical journal of Australia.

[176]  Zipes Dp,et al.  Cardiac ganglionitis associated with sudden unexpected death. , 1979 .

[177]  A. Banks,et al.  Anabolic steroids in athelics: crossover double-blind trial on weightlifters. , 1975, British medical journal.

[178]  P. D. White.  BRADYCARDIA (BELOW RATE OF 40) IN ATHLETES, ESPECIALLY IN LONG DISTANCE RUNNERS , 1942 .

[179]  C. Andersen,et al.  Plakoglobin: A diagnostic marker of arrhythmogenic right ventricular cardiomyopathy in forensic pathology? , 2015, Forensic Science, Medicine, and Pathology.

[180]  B. Maron,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology. , 2015, Journal of the American College of Cardiology.

[181]  M. Mendes,et al.  The hearts of competitive athletes: an up-to-date overview of exercise-induced cardiac adaptations. , 2015, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[182]  B. Maron,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology. , 2015, Journal of the American College of Cardiology.

[183]  R. Bonow,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. , 2015, Journal of the American College of Cardiology.

[184]  M. Link,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology. , 2015, Journal of the American College of Cardiology.

[185]  H. Bratzke,et al.  Cardiac channelopathy causing sudden death as revealed by molecular autopsy , 2012, International Journal of Legal Medicine.

[186]  A. Baggish,et al.  Contemporary Reviews in Cardiovascular Medicine Athlete's Heart and Cardiovascular Care of the Athlete Scientific and Clinical Update , 2011 .

[187]  M. Sheppard,et al.  Guidelines for autopsy investigation of sudden cardiac death , 2007, Virchows Archiv.

[188]  It Istituto Superiore di Sanit,et al.  Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and , 2005 .

[189]  F. Martínez-Díaz,et al.  Expression and significance of cell immunohistochemical markers (HHF-35, CD-31, Bcl-2, P-53 and apopDETEC) in hypertrophic cardiomyopathy. , 2004, Histology and histopathology.

[190]  Sanjay Sharma.  Athlete's heart--effect of age, sex, ethnicity and sporting discipline. , 2003, Experimental physiology.

[191]  F. Marcus,et al.  Electrocardiographic features of inherited diseases that predispose to the development of cardiac arrhythmias, long QT syndrome, arrhythmogenic right ventricular cardiomyopathy/dysplasia, and Brugada syndrome. , 2000, Journal of electrocardiology.

[192]  R. Jeresaty.  Mitral valve prolapse: definition and implications in athletes. , 1986, Journal of the American College of Cardiology.